Literature DB >> 31941240

[Chinese guidelines on the management of liver cirrhosis].

.   

Abstract

Based on reviews of literature and experts' consensus, the Chinese Society of Hepatology developed the following guideline on the diagnosis and treatment of liver cirrhosis aiming to improve clinical practice.In addition to what has been covered in the previously published guidelines on the management of cirrhosis complications, the guideline adds new sections and provides updates. The guidelines emphasize the early diagnosis of the cause and assessment of the complications. Comprehensive treatment including etiological treatment, and complication management should be initiated immediately. In addition, regular monitoring, especially surveillance of hepatocellular carcinoma is crucial to manage patients.

Entities:  

Keywords:  Diagnosis; Guideline; Liver cirrhosis; Treatment

Mesh:

Year:  2019        PMID: 31941240     DOI: 10.3760/cma.j.issn.1007-3418.2019.11.008

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  11 in total

1.  Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.

Authors:  Yujing Xin; Xinyuan Zhang; Yi Yang; Yi Chen; Yanan Wang; Xiang Zhou; Xiao Li
Journal:  J Gastrointest Oncol       Date:  2021-12

2.  Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury.

Authors:  Xian He; Ming-Xi Zhou; Cheng Cheng; Shan-Shan Li; Yuan Gao; Zhi-Tao Ma; Xin-Hua Song; Zhao-Fang Bai; Zheng-Sheng Zou; Xiao-He Xiao; Jia-Bo Wang; Ya-Wen Lu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

3.  Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy.

Authors:  Youwen Hu; Zhili Wen
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

4.  Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease.

Authors:  Qian Zhang; Hong Peng; Xiaoqing Liu; Huimin Wang; Jinjie Du; Xinhua Luo; Hong Ren; Peng Hu
Journal:  J Clin Transl Hepatol       Date:  2021-05-07

5.  Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection.

Authors:  Qingqing Fang; Wei Chen; Yourong Jian; Yu Li; Wei Lian; Hongyu Wan; Shiyao Chen; Feng Li; Ying Chen
Journal:  J Healthc Eng       Date:  2022-02-24       Impact factor: 2.682

6.  Long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure: a retrospective study.

Authors:  Lu Wang; Wenxiong Xu; Xuejun Li; Dabiao Chen; Yeqiong Zhang; Yuanli Chen; Juan Wang; Qiumin Luo; Chan Xie; Liang Peng
Journal:  BMC Gastroenterol       Date:  2022-04-02       Impact factor: 3.067

7.  Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B-A Retrospective Cohort Study.

Authors:  Qing-Xia Wang; Jiao Xue; Mei-Jie Shi; Yu-Bao Xie; Huan-Ming Xiao; Sheng Li; Ming Lin; Xiao-Ling Chi
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-02       Impact factor: 3.249

8.  Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.

Authors:  Yujing Xin; Fei Cao; Hongcai Yang; Xinyuan Zhang; Yi Chen; Xiaojing Cao; Xiang Zhou; Xiao Li; Jinxue Zhou
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

9.  TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma.

Authors:  Lihua Yu; Xiaoli Liu; Xinhui Wang; Fengna Yan; Peng Wang; Yuyong Jiang; Juan Du; Zhiyun Yang
Journal:  Oncoimmunology       Date:  2021-06-28       Impact factor: 8.110

10.  Analysis of Risk Factors of Bleeding Complications in Percutaneous Needle Biopsy of Liver Occupying Lesions.

Authors:  Wei Cao; Zhimei Cheng; Lizhou Wang; Xuya Zhao; Junxiang Li; Shi Zhou
Journal:  Int J Gen Med       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.